So are they saying that cancer cells operate anaerobically? I mean, that is what happens when you stop at glycolysis and don’t complete Kreb’s (a chemical cycle in the mitochondrion).
And I wonder what about turning on the mitochondrion (and thus allowing the cell to produce vast amounts of additional energy aerobically) would cause them to die. I am skeptical...
Has there ever been a cheap, safe cure for any cancer? In the history of medicine?
So are they saying that cancer cells operate anaerobically? I mean, that is what happens when you stop at glycolysis and don’t complete Kreb’s (a chemical cycle in the mitochondrion).
I saw a student article about how the Media (as well as any private funding sources) have ignored this possible cheap, safe, cancer treatment. Being a skeptic, I checked it out. Because you might think a possible cure for ANY cancer would be big news. And a safe, known substance, that is dirt cheap and can be tested in Phase II right away, would be really big news. That the Media would just ignore this, doesn't make sense. Conspiracy theory and all that.
So Google me some News.
Results 1 - 10 of about 59 for Dichloroacetate.
Hmmm, very few stories, hardly any MegaMedia names at all there. A lot of woo sounding stuff about how it won't get funding, how this discovery is being ignored by the press, how it will never be tested.
Maybe Google isn't working. Lets search for acetate.
416 for acetate.
OK, Google is working. (damn, a lot of stories about acetate, breaking news there)
So being a skeptic, check some News sites.
FOX
http://search2.foxnews.com/search?i...*&filter=0&sort=date:D:S:d1&q=Dichloroacetate
0 results
ABC
http://abcnews.go.com/search?searchtext= Dichloroacetate&type=feature
0 hits
NBC
http://nbc.resultspage.com/search?ts=custom&p=Q&uid=400427844&w=Dichloroacetate
0 hits
BBC
http://search.bbc.co.uk/cgi-bin/sea...tate&btn=Search&uri=/?ok&scope=all&go=toolbar
Sorry
There are no results for "Dichloroacetate" on the BBC website.
WTF? Did I spell this wrong?
http://en.wikipedia.org/wiki/Dichloroacetate
No, that is correct. OK something is fookin nuts here.
http://www.msnbc.msn.com/?search=MS...bmit=Search&id=11881780&FORM=AE&os=0&gs=1&p=1
3 hits
Aha! See? The media isn't ignoring the story! No wait, those are all stories about the original story. Jan 22, 23 2007
Hmmm... OK skeptics, debunkin time.
Google News search for "Cancer" stories, 66,838 for cancer.
Google News for cancer+dichloroacetate
about 58 for cancer dichloroacetate.
WTF???
![]()
Looks like the media is ignoring the story. How strange.
The other concern is that the substance is quite toxic. One of the other posters suggested that it may be useful for patients with non-cancer mitochondrial defects. The answer is: it's been tried, but has limited appeal due to its toxicity.
http://www.ktre.com/Global/story.asp?S=6040425&nav=2FH5According to the authors of the report, DCA is nontoxic and is currently used in children who have a rare genetic condition where they produce too much lactic acid.
They go on to point out that DCA is used in these children to reverse the condition with minimal or no side effects.
http://www.topcancernews.com/news/5...or-DCA-is-a-potentially-new-anti-cancer-agentAnd while this type of research may not ordinarily generate a lot of excitement, this specific study is creating a buzz because DCA has been safely used in humans for decades, without adverse side effects.
http://www.msnbc.msn.com/id/16776882/site/newsweek/But DCA has one big advantage over most of those: it is an existing drug whose side effects are well-studied and relatively tolerable.
Or Possibly that 'three minutes of google search' = 'comprehensive review of the media' is a flawed theory. One problem with search engines at network news is that they purge stories after a couple of days. It also doesn't necessarily reflect what they broadcast. Remember: most news is created by the local affiliates, not by the network.
I checked, and Google News doesn't purge after a few days. But it is obvious Google News doesn't show every news story either.
EDMONTON, Jan. 23 /CNW/ - Kimmo Lucas, President and CEO of CardioMetabolics Inc. (CMI) commented today on the increased public interestin DCA (Dichloroacetate), from unrelated news announcements referring to DCA as a "breakthrough drug for the treatment of cancer" -specifically for patients requiring cancer chemotherapy.
"CMI's technology related to the metabolic modulator DCA shows promise in
treating various conditions and disease states, including prevention of reperfusion injury in open heart surgical procedures, acute coronarysyndromes, diabetes and angina. Other potential applications include obesity and cancer. The common element in treating these diverse diseases is the drug's special ability to positively impact the metabolism of energy. As well, CMI's technology extends to related DCA compounds and which appear to have similar mechanisms of action. The company has research planned or ongoing in all aforementioned areas and which is covered by intellectual property protection," said Lucas.
To date, CMI has been granted four Patents from the USPTO (United States Patent & Trademark Office) and has several other patent applications pending.
Two of the issued patents relate to DCA, while the other two cover related compounds of DCA. CMI's patent coverage includes the treatment of cardiovascular diseases and metabolic conditions where ischemic or hypoxic conditions present (such as cardiac surgery), as well as the other disease states mentioned above.
CMI X-11S (DCA intravenous formulation) is the company's lead clinical stage drug product. CMI has secured permission from the US Food and Drug Administration (FDA) under a Special Protocol Assessment (SPA) and from the CDN Therapeutic Product Directorate (TPD) to initiate Phase III clinical trials for cardiac surgery in higher risk geriatric patients. Other potential applications are earlier stage candidates and the company cautions that much work remains to develop them. Although early results are promising, it may take years of research to prove efficacy in humans.
CMI is currently undergoing a round of financing and in discussions with strategic drug partners. The company is focused on unlocking the potential of this exciting drug and its related compounds.
This press release may contain forward-looking statements, including the Company's belief as to the potential of its products, the Company's expectations regarding the issuance of additional patents, the Company's ability to protect its intellectual property, and involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Other risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the ability to economically manufacture its products, the potential of its products, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize its products, the ability of the Company to defend its patents from infringement by third parties, and the risk that the Company's patents may be subsequently shown to be invalid or infringe the patents of others. Investors are cautioned against placing undue reliance on forward-looking statements.
Background Information
DCA has the potential to help improve the lives of millions of patients.In the US alone, the combined direct and indirect cost of treatment for cardiovascular disease was estimated at $365 billion US and with diabetes a $172 billion US (American Heart Association, 2005). Global drug treatment costs for cancer worldwide are estimated at $40 billion (Market Research 2005).
CardioMetabolics Inc. (CMI) is an Edmonton-based, privately held, company. CMI was established in 2000. The Company holds the worldwide exclusive rights to the technologies which are licensed from the University of Alberta. CMI's product development focuses on the development of cost effective drugs that address unmet needs not adequately served by products currently on the market. The company's mission is to develop cost effectivedrugs to improve the lives of patients suffering from cardiovascular or other diseases.
For further information: Kimmo Lucas, President & CEO, CardioMetabolics
Inc., Cell: (780) 722-8367
I did. All the patients in the study I linked to - which is a peer-reviewed study in a medical journal - died.
http://content.nejm.org/cgi/content...is&searchid=1&FIRSTINDEX=0&resourcetype=HWCITNo serious drug-related toxicity occurred. We conclude that dichloroacetate is a safe and effective adjunct in the treatment of patients with lactic acidosis
Your links appear to be TV channels. Are you saying reporters (who probably researched the story for all of half an hour) are more accurate than peer-reviewed journals (whose authors probably worked with this substance for years)?.
Sigma-Aldrich lists the following from its search page at:
http://www.sigmaaldrich.com/catalog/search/AdvancedSearchPage
I let this pass; but now it seems I should not have done so because people are trying to find the wrong stuff. The only relevant products are the isolated, bolded salts. Even then, I suppose the one that was studied was the sodium salt. An amateur, data-dump like this can really hurt a desperate person who can't tell the differences among the compounds.Ethyl dichloroacetate (1)
Methyl dichloroacetate (2)
Methyl dichloroacetate solution (1)
Methyl dichloroacetate-1-13C (1)
Potassium dichloroacetate (1)
Sodium dichloroacetate (1)
5-ALPHA-CHOLESTAN-3-BETA-YL DICHLOROACETATE (1)
ANDROST-5-EN-3-BETA-YL DICHLOROACETATE (1)
CHOLEST-5-EN-3-BETA-YL DICHLOROACETATE (1)
ETHYL DICHLOROACETATE (1)
And on the other, other hand, if you were dying of cancer, would you try an experimental treatment? I would. If it works, I'm cured. If it doesn't, I was gonna die in incredible pain anyway. Seems like a pretty good trade-off to me.
Here's a question: anybody done a little quick research on the incidence of cancer among those patients who have been receiving this treatment compared to the general population? Seems to me like it's a quick way to gather some evidence; not conclusive, but not a bad idea either.
http://www.stanford.edu/group/hopes/treatmts/ebuffer/j4.htmlIn clinical trials where dichloroacetate is used as a medical drug, no major side effects have been reported.
http://health.yahoo.com/experts/healthnews/2008/dca-long-awaited-cancer-killer-not-so-fastThough the authors of the article in New Scientist state that DCA is safe and causes few side effects, previous studies have shown that it can damage nerves and cause pain in some people.
Yep. It would be real easy to do ...r heirs will not sue you if the patient dies.
This would only be true for hopeless cases.
And in those cases the new cure would probably not work anyway.
The majority of cases have some chance of healing with irradiation, and it is difficult to find subjects that will forego[sic] this chance for a new unproven cure, and you can be sure that their heirs will not sue you if the patient dies.